Role of sorLA in trafficking and processing of APP

M. Andersen, PhD
Max-Delbrueck Center for Molecular Medicine (Berlin, Germany)
Year Awarded:
Grant Duration:
April 1, 2005 to March 31, 2007
Alzheimer's Disease
Award Amount:
Grant Reference ID:
Award Type:
Award Region:

Role of sorLA in trafficking and processing of APP


A hallmark of the brain in Alzheimer's disease is the occurrence of “plaques,” dense deposits of proteinaceous material that are toxic to nerve cells. Plaques are mainly composed of a small peptide called the amyloid-beta (Aβ), which is derived from a larger protein in nerve cells, the amyloid precursor protein (APP). Dr. Anderson has identified a novel protein in nerve cells called sorLA that seems to play an important role in the APP breakdown into Aβ. His studies suggest that sorLA prevents APP from going into specific compartments of the nerve cell where breakdown into Aβ occurs. He believes that raising sorLA levels will prevent Aβ production, and therefore significantly decrease, or even eliminate, plaque accumulation in the brain. If confirmed, Dr. Anderson's studies could be used to develop new ways to combat Alzheimer's disease through drugs designed to increase sorLA levels in the brain.


Andersen, O.M. and Willnow, T.E. (2006) Lipoprotein receptors in Alzheimer's disease. Trends Neurosci. Dec;29(12):687-94.  

Willnow, T.E. and Andersen, O.M. (2006) Pin-pointing APP processing. Mol. Interv. Jun;6(3):137-9.  

Andersen, O.M., Schmidt, V., Spoelgen, R., Gliemann, J., Behlke, J., Galatis, D., McKinstry, W.J., Parker, M.W., Masters, C.L., Hyman, B.T., Cappai, R. and Willnow, T.E. (2006) Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11. Biochemistry. Feb 28;45(8):2618-28.  

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.